Clinical trials: Streptococcus Pneumoniae Vaccines

Immune Tolerance

Pneumococcal Conjugate Vaccine Followup

• Completed
• Age: 3 to 5 years
• Phase 2

Recently, controversy has emerged regarding the role of the 23vPPV in infants due to potential immunological hypo-responsiveness (i.e. a poorer immune response to repeat vaccination).

Trial name

PCVFU (NCT01414504)

Testing

Prevenar + PPV, Infant PCV (Prevenar) + PPV at 9 months, No Prevenar + PPV at 9 months

Where

Papua New Guinea

Volunteers

280 people, healthy volunteers welcome

Sponsor

William Pomat